Development of modified r-type bacteriocins to specifically target c. Difficile and prevent relapse of cdis

Ended Project Grant Awarded Last action

Award ID
R33AI121692
Recipient
Awarding agency
Obligated
$1,307,122

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $1,422,900.00 Federal
  • -$115,778.00 Non-federal
Place of performance
South San Francisco, CA 94080, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$8,395 $0
Amendment -$8,395 $0
Amendment $30,409 $0
Amendment -$30,409 $0
Amendment -$30,409 $0
Amendment $30,409 $0
Amendment -$30,409 $0
Amendment $30,409 $0
Amendment $60,818 $0
Amendment $60,818 $0
Amendment $60,818 $0
Amendment -$30,409 $0
Amendment -$30,409 $0
Amendment -$30,409 $0
Amendment -$30,409 $0
Amendment -$30,409 $0
Amendment -$30,409 $0
Amendment -$510 $0
Amendment -$510 $0
Amendment -$510 $0
Amendment $255 $0
Amendment $255 $0
Amendment $255 $0
Amendment $30 $0
Amendment $30 $0
Amendment $30 $0
Amendment $30,634 $0
Amendment $30,634 $0
Amendment $30,634 $0
Amendment -$115,778 $0
Amendment -$115,778 -$115,778
Amendment $0 $0
Amendment $0 $0
Amendment $525,456 $0
Amendment $530,308 $0
Amendment Title: development of modified r-type bacteriocins to specifically target c. Difficileand prevent relapse of cdis. $0 $0
Amendment $0 $0
Original award $524,255 $0
Show all 38

Quick answers

Who received award R33AI121692?

R33AI121692 was awarded to Pylum Biosciences, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 1, 2015.

How much is award R33AI121692 worth?

$1,307,122 has been obligated on R33AI121692: $1,422,900 in federal funding and -$115,778 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award